We will hear about the opportunities and challenges of RWE for researchers and industry and how traditional methods of evidence generation from electronic health records are no longer fit for purpose. Discover how AI techniques such as clinical natural language processing (cNLP) can generate deep RWE for new insights, pioneering patient solutions, alongside greater clinical and economic value for industry.
RWE from the perspectives of the principal investigator and the pharma executive
The limitations of traditional methods of evidence generation from electronic health records
The benefits of AI-based techniques such as cNLP
A gold standard for high-quality RWE for deeper insights at scale and speed